It s been a long, hard road, but after a few years of rejections, Arena Pharmaceuticals weight-loss drug lorcaserin finally won over an FDA advisory panel: They voted 18-to-4 last week in favor of approving the drug. Though the panel s decision is not final, the FDA which will rule on the matter by June 27 usually follows the advisory committee s recommendations.
It s been a long, hard road, but after a few years of rejections, Arena Pharmaceuticals weight-loss drug lorcaserin finally won over an FDA advisory panel: They voted 18-to-4 last week in favor of approving the drug. Though the panel s decision is not final, the FDA which will rule on the matter by June 27 usually follows the advisory committee s recommendations.